These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20921905)

  • 1. Mixed variant multicentric Castleman disease treated with rituximab: case report.
    Mian H; Leber B
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):622. PubMed ID: 20921905
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease.
    Casquero A; Barroso A; Fernández Guerrero ML; Górgolas M
    Ann Hematol; 2006 Mar; 85(3):185-7. PubMed ID: 16341862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1RA agonist (anakinra) in the treatment of multifocal castleman disease: case report.
    Galeotti C; Tran TA; Franchi-Abella S; Fabre M; Pariente D; Koné-Paut I
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):920-4. PubMed ID: 19131781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Is the best treatment for HIV-associated multicentric Castleman disease?
    Bower M; Dalla Pria A
    Clin Adv Hematol Oncol; 2012 Mar; 10(3):207-9. PubMed ID: 22402432
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure of rituximab in human immunodeficiency virus-associated multicentric Castleman disease.
    Neuville S; Agbalika F; Rabian C; Brière J; Molina JM
    Am J Hematol; 2005 Aug; 79(4):337-9. PubMed ID: 16044438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena.
    Ocio EM; Sanchez-Guijo FM; Diez-Campelo M; Castilla C; Blanco OJ; Caballero D; San Miguel JF
    Am J Hematol; 2005 Apr; 78(4):302-5. PubMed ID: 15795923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete remission in 4 patients with human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin, a novel chemotherapy combination.
    Peker D; Martinez AE; Schwartz MA; Cusnir M
    Clin Adv Hematol Oncol; 2012 Mar; 10(3):204-6. PubMed ID: 22402431
    [No Abstract]   [Full Text] [Related]  

  • 8. Multicentric Castleman's disease & HIV infection.
    Cotter A; Lambert J; O'Gorman P
    Ir Med J; 2009 Oct; 102(9):294-5. PubMed ID: 19902650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide.
    Stary G; Kohrgruber N; Herneth AM; Gaiger A; Stingl G; Rieger A
    AIDS; 2008 Jun; 22(10):1232-4. PubMed ID: 18525273
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody.
    Gholam D; Vantelon JM; Al-Jijakli A; Bourhis JH
    Ann Hematol; 2003 Dec; 82(12):766-8. PubMed ID: 12898190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab and thalidomide combination therapy for Castleman disease.
    Ramasamy K; Gandhi S; Tenant-Flowers M; Ceesay M; Corderoy S; Marcus R; Schey S
    Br J Haematol; 2012 Aug; 158(3):421-3. PubMed ID: 22583139
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasmablastic microlymphoma arising in human herpesvirus-8-associated multicentric Castleman disease in a human immunodeficiency virus-seronegative patient with clinical response to anti-interleukin-6 therapy.
    Koenig G; Stevens TM; Peker D
    Histopathology; 2015 Dec; 67(6):930-2. PubMed ID: 25900626
    [No Abstract]   [Full Text] [Related]  

  • 13. Multicentric Castleman disease: report of rare disease in Kuwait.
    Mohammad BA; Al-Brahim N; Kunjhibava S; Ahmad M; Ahmad M
    Gulf J Oncolog; 2009 Jul; (6):48-50. PubMed ID: 20194090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-POEMS variant).
    Sobas MA; Alonso Vence N; Diaz Arias J; Bendaña Lopez A; Fraga Rodriguez M; Bello Lopez JL
    Ann Hematol; 2010 Feb; 89(2):217-9. PubMed ID: 19636554
    [No Abstract]   [Full Text] [Related]  

  • 15. Vinblastine, rituximab and HAART, treatment of an HIV -positive patient with multicentric Castleman's disease.
    van Aalderen MC; Brinkman K; van den Berk GE; Terpstra WE
    Neth J Med; 2010 Feb; 68(2):87-90. PubMed ID: 20167961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Castleman disease infiltrating great vessels and right atrium.
    Garcipérez de Vargas FJ; Vega J; Fernández H; Mogollón MV; Porro R; Gómez-Barrado JJ
    Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):669-70. PubMed ID: 22137469
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoimmune pancreatitis in the setting of Castleman disease.
    Maithel SK; Pratt W; Kelleher T; Avigan D; Goldman H; Pfeifer W; Pihan GA; Vollmer CM
    Pancreas; 2007 Nov; 35(4):384-7. PubMed ID: 18090252
    [No Abstract]   [Full Text] [Related]  

  • 18. Near-total resolution of multicentric Castleman disease by prolonged treatment with thalidomide.
    Starkey CR; Joste NE; Lee FC
    Am J Hematol; 2006 Apr; 81(4):303-4. PubMed ID: 16550518
    [No Abstract]   [Full Text] [Related]  

  • 19. Multicentric Castleman disease complicated by tumor lysis syndrome after systemic chemotherapy.
    Lee JH; Kwon KA; Lee S; Oh SY; Kwon HC; Han JY; Hong SH; Kim SH
    Leuk Res; 2010 Jan; 34(1):e42-5. PubMed ID: 19747731
    [No Abstract]   [Full Text] [Related]  

  • 20. Castleman disease.
    Dham A; Peterson BA
    Curr Opin Hematol; 2007 Jul; 14(4):354-9. PubMed ID: 17534161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.